OSVALDO BAEZ: Open Payments
NPI 1407444524 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,793 in 87 payments from 18 companies in 2025. Trend: 2023 $580 · 2024 $1,625 · 2025 $1,793
Food & beverage: $1,793
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $602 |
| Janssen Biotech, Inc. | 20 | $375 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $122 |
| Aimmune Therapeutics, Inc. | 4 | $101 |
| Madrigal Pharmaceuticals | 5 | $86 |
| Ardelyx, Inc. | 4 | $81 |
| Ipsen Biopharmaceuticals, Inc | 3 | $80 |
| Lilly USA, LLC | 3 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $64 |
| Gilead Sciences, Inc. | 1 | $33 |
Products named: TREMFYA, RINVOQ, CREON, LINZESS, ENTYVIO, ZENPEP, REZDIFFRA, IBSRELA.
Industry payments across FL — which companies pay providers there.
